3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Sarcoma
39
Leiomyosarcoma
10
Osteosarcoma
8
Breast Neoplasms
5
Small Cell Lung Carcinoma
4
Pancreatic Neoplasms
4
Ovarian Neoplasms
4
Neuroectodermal Tumors, Primitive, Peripheral
4
Neoplasm Metastasis
4
Melanoma
4
Liposarcoma
4
Histiocytoma, Malignant Fibrous
4
Chondrosarcoma
4
Carcinoma, Non-Small-Cell Lung
4
Stomach Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Sarcoma, Synovial
3
Salivary Gland Neoplasms
3
Prostatic Neoplasms
3
Hemangiosarcoma
3
Esophageal Neoplasms
3
Dermatofibrosarcoma
3
Colorectal Neoplasms
3
Bone Neoplasms
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Sarcoma, Kaposi
2
Rhabdomyosarcoma
2
Recurrent Uterine Corpus Sarcoma
2
Neuroblastoma
2
Interventions
Nivolumab
2
Imatinib Mesylate
2
pembrolizumab
1
Surveys and Questionnaires
1
Specimen Handling
1
Quality of Life
1
Protons
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Immunotherapy
1
Drug Therapy
1
Docetaxel
1
Cyclophosphamide
1
CTLA-4 Antigen
1
Blood Specimen Collection
1
Biological Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Adenoid Cystic
×
Docetaxel
×
Sarcoma
×
Clear all
NCT04140526
2025-05-23
PRESERVE-001
OncoC4, Inc.
Phase 1/2
Active not recruiting
733 enrolled